Autosomal recessive spastic paraplegia type 21

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

Regulatory Watchboard

4 events
Oct 2025Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

TrialRECRUITING
May 2024Budesonide as a Treatment for Functional Dyspepsia

Universitaire Ziekenhuizen KU Leuven — PHASE4

TrialRECRUITING
Jan 2024Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.

University of Thessaly

TrialRECRUITING
Sep 2022Prevalence of Mast Cell Activation Syndrome in Patients With EDS With Digestive Disorders

Lille Catholic University

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Autosomal recessive spastic paraplegia type 21.
Check the disease page for updates →

Clinical Trial Landscape

No active clinical trials currently recruiting for Autosomal recessive spastic paraplegia type 21.
Search all trials →
Search clinical trials for Autosomal recessive spastic paraplegia type 21

Recent News & Research

No recent news articles indexed yet for Autosomal recessive spastic paraplegia type 21.
Search PubMed for Autosomal recessive spastic paraplegia type 21

Browse all Autosomal recessive spastic paraplegia type 21 news →

Specialist Network

No specialists currently listed for Autosomal recessive spastic paraplegia type 21.

View all Autosomal recessive spastic paraplegia type 21 specialists →

Quick Actions